Deletion of <i>CDKN2A/B</i> is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemiaM. K. Kathiravan, Shano Naseem, Minu Singh et al.|Leukemia & lymphoma/Leukemia and lymphoma|2018Cited by 38
Autologous stem cell transplant for high‐risk neuroblastoma: Achieving cure with low‐cost adaptationsRicha Jain, Deepak Bansal, Rekha Hans et al.|Pediatric Blood & Cancer|2020Cited by 33
Clinical and Prognostic Impact of Copy Number Alterations and Associated Risk Profiles in a Cohort of Pediatric B-cell Precursor Acute Lymphoblastic Leukemia Cases Treated Under ICiCLe ProtocolSanjeev Gupta, Prateek Bhatia, Sameer Bakhshi et al.|HemaSphere|2022Cited by 16
Aplastic anemia in children: How good is immunosuppressive therapy?Richa Jain, Neelam Varma, Amita Trehan et al.|Pediatric Hematology and Oncology|2019Cited by 15
60th Annual Conference of Indian Society of Hematology & Blood Transfusion (ISHBT) October 2019Kanwaljeet Singh, Ankur Ahuja, Tathagatta Chatterjee et al.|Indian Journal of Hematology and Blood Transfusion|2019Cited by 14